All Type of News
Enbrel gears up share
Wyeth’s Enbrel generated the strongest growth in the domestic rheumatoid arthritis market.
Enbrel is the only soluble tumor necrosis factor (TNF) receptor approved to reduce signs and symptoms, induce major clinic...
Lawmaker proposed bill to notify drug import related affairs
A bill to ensure the effective management of imported drug business was proposed by Rep Lim Doo-sung of the ruling Grand National Party on November 27.
Under the proposed rule, a drug importer may notify its change...
Allergan Korea seeks sole marketing of Botox
Allergan Korea says it would stop the joint marketing of an antiwrinkle therapy Botox with Daewoong Pharm to conduct its sole marketing from next January.
Daewoong honored Allergan’s sole marketing in consideration...
Korean drugmakers look to rapidly growing orphan drug market
The total worldwide market for orphan drugs is expected to rise at an AAGR (average annual growth rate) of 9.1% to reach $43.6 billion in 2008, according to market experts.
The future of the orphan drug industry wi...
Boryung puts out ARB antihypertensive agent
Boryung says it has launched its new antihypertensive medicine containing losartan kalium, angiotensin II antagonist, through its own formulation technology.
This medicine works by preventing the action of a hormo...
Rosy prospect expected for leading drug firms next year
Optimism is growing over next year’s outlook for major Korean pharmaceutical companies as there is growing market demand for pharmaceuticals due to the nation’s “aged society'' amid a rapid increase in the number of s...
Dong-A on bumpy road over Stillen
Dong-A Pharm is likely to face a bumpy road next year as many pharmaceutical manufacturers will rush to introduce the first version of Stillen capsule, one of Dong-A’s flagship products for treatment of gastritis, as ...
Bayer hopes to stay ahead of rivals with aggressive marketing
As the pendulum of the pharmaceutical industry is shifting from the West to the East, countries in Asia and Pacific region is set to become the largest drug market in the world.
Although Bayer Schering Korea has en...
Government to freeze health insurance premium
The Ministry for Health, Welfare and Family Affairs announced on November 27 that it decided to freeze the National Health Insurance premium for 2009 for the first time ever, despite expanded coverage as economic diff...
New Korea Biotechnology Association sets sail
The inauguration ceremony for the newly formed Korea Biotechnology Association was held in Imperial Palace hotel in Seoul on November 28 through integration of three biotechnology organizations as part of efforts to u...
